Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyCellularComponentactin cytoskeleton

ACACA TJP1 PPP1R9A TMEM63B SEPTIN11 TSC1 CTTNBP2NL PALLD

2.29e-04576608GO:0015629
GeneOntologyCellularComponentlamellipodium

KCNA2 PPP1R9A TSC1 CTTNBP2NL PALLD

5.15e-04230605GO:0030027
GeneOntologyCellularComponentcell leading edge

KCNA2 PTPRJ PPP1R9A PECAM1 TSC1 CTTNBP2NL PALLD

5.55e-04500607GO:0031252
GeneOntologyCellularComponentseptin complex

SEPTIN11 SEPTIN10

7.21e-0414602GO:0031105
GeneOntologyCellularComponentseptin ring

SEPTIN11 SEPTIN10

7.21e-0414602GO:0005940
GeneOntologyCellularComponentseptin cytoskeleton

SEPTIN11 SEPTIN10

9.47e-0416602GO:0032156
DomainTeashirt_fam

TSHZ3 TSHZ2 TSHZ1

2.99e-083593IPR027008
Pubmed

Teashirt 3 expression in the chick embryo reveals a remarkable association with tendon development.

TSHZ3 TSHZ2 TSHZ1

5.13e-09361316631416
Pubmed

Analysis of TSHZ2 and TSHZ3 genes in congenital pelvi-ureteric junction obstruction.

TSHZ3 TSHZ2 TSHZ1

5.13e-09361319745106
Pubmed

Three putative murine Teashirt orthologues specify trunk structures in Drosophila in the same way as the Drosophila teashirt gene.

TSHZ3 TSHZ2 TSHZ1

5.13e-09361314973285
Pubmed

The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1.

USP34 CCDC137 DCAF8 ACACA CUL9 TRIP11 CTTNBP2NL

9.34e-0821261733853758
Pubmed

FE65 binds Teashirt, inhibiting expression of the primate-specific caspase-4.

TSHZ3 TSHZ2 TSHZ1

1.79e-07761319343227
Pubmed

Expression patterns of the three Teashirt-related genes define specific boundaries in the developing and postnatal mouse forebrain.

TSHZ3 TSHZ2 TSHZ1

2.86e-07861315834955
Pubmed

Mechanosensitive mTORC1 signaling maintains lymphatic valves.

ESCO2 PECAM1 TSC1

4.28e-07961337036444
Pubmed

The planar cell polarity gene Vangl2 is required for mammalian kidney-branching morphogenesis and glomerular maturation.

TSHZ3 FRAS1 EGF TSHZ2 TSHZ1

7.21e-079561520843830
Pubmed

PERB11 (MIC): a polymorphic MHC gene is expressed in skin and single nucleotide polymorphisms are associated with psoriasis.

MICB MICA

3.03e-06261210691930
Pubmed

[The study on the haplotype of MICA and MICB microsatellite locus in Guangzhou Han population].

MICB MICA

3.03e-06261215640005
Pubmed

MICA/B expression in macrophage foam cells infiltrating atherosclerotic plaques.

MICB MICA

3.03e-06261224997223
Pubmed

Inhibition of the HDAC/Suv39/G9a pathway restores the expression of DNA damage-dependent major histocompatibility complex class I-related chain A and B in cancer cells.

MICB MICA

3.03e-06261228677817
Pubmed

Reversal of epigenetic silencing of MHC class I chain-related protein A and B improves immune recognition of Merkel cell carcinoma.

MICB MICA

3.03e-06261226902929
Pubmed

Associations between MICA and MICB Genetic Variants, Protein Levels, and Colorectal Cancer: Atherosclerosis Risk in Communities (ARIC).

MICB MICA

3.03e-06261236958849
Pubmed

Associations of high-resolution-typing-defined MICA and MICB polymorphisms, and the levels of soluble MICA and MICB with Oral Squamous Cell Carcinoma in Bulgarian patients.

MICB MICA

3.03e-06261233835601
Pubmed

Selective regulation of H1 histamine receptor signaling by G protein-coupled receptor kinase 2 in uterine smooth muscle cells.

GRK2 HRH1

3.03e-06261218511496
Pubmed

Impact of MICA-TM, MICB-C1_2_A and C1_4_1 microsatellite polymorphisms on the susceptibility to chronic periodontitis in Germany.

MICB MICA

3.03e-06261221388352
Pubmed

Diversity and characterization of polymorphic 5' promoter haplotypes of MICA and MICB genes.

MICB MICA

3.03e-06261224962621
Pubmed

A role for the MHC class I-like Mill molecules in nutrient metabolism and wound healing.

MICB MICA

3.03e-06261218560379
Pubmed

Association of MICA and MICB alleles with symptomatic dengue infection.

MICB MICA

3.03e-06261221762746
Pubmed

In vivo expression pattern of MICA and MICB and its relevance to auto-immunity and cancer.

MICB MICA

3.03e-06261217565371
Pubmed

Conserved amino acids within the adenovirus 2 E3/19K protein differentially affect downregulation of MHC class I and MICA/B proteins.

MICB MICA

3.03e-06261219949079
Pubmed

AluyMICB dimorphism within the class I region of the major histocompatibility complex is associated with asthma and airflow obstruction in the Busselton population.

MICB MICA

3.03e-06261216776673
Pubmed

Major Histocompatibility Complex Class I Chain-Related A and B (MICA and MICB) Gene, Allele, and Haplotype Associations With Dengue Infections in Ethnic Thais.

MICB MICA

3.03e-06261232737971
Pubmed

MHC class I chain-related protein A and B (MICA and MICB) are predominantly expressed intracellularly in tumour and normal tissue.

MICB MICA

3.03e-06261228334733
Pubmed

Hepatitis B surface antigen inhibits MICA and MICB expression via induction of cellular miRNAs in hepatocellular carcinoma cells.

MICB MICA

3.03e-06261223917076
Pubmed

Propionic acid secreted from propionibacteria induces NKG2D ligand expression on human-activated T lymphocytes and cancer cells.

MICB MICA

3.03e-06261219553547
Pubmed

Association of MICA-TM and MICB C1_2_A microsatellite polymorphisms with tumor progression in patients with colorectal cancer.

MICB MICA

3.03e-06261219353249
Pubmed

2-deoxy D-glucose prevents cell surface expression of NKG2D ligands through inhibition of N-linked glycosylation.

MICB MICA

3.03e-06261222227571
Pubmed

Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid.

MICB MICA

3.03e-06261212569559
Pubmed

Clinical significance of tumor expression of major histocompatibility complex class I-related chains A and B (MICA/B) in gastric cancer patients.

MICB MICA

3.03e-06261226708143
Pubmed

Expression and regulation of mouse Mtsh1 during limb and branchial arch development.

TSHZ2 TSHZ1

3.03e-06261211668608
Pubmed

Bimodal regulation of the human H1 histamine receptor by G protein-coupled receptor kinase 2.

GRK2 HRH1

3.03e-06261215542600
Pubmed

Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia.

MICB MICA

3.03e-06261212714493
Pubmed

MICA and MICB microsatellite alleles in HLA extended haplotypes.

MICB MICA

3.03e-06261211881819
Pubmed

Allelic and interlocus comparison of the PERB11 multigene family in the MHC.

MICB MICA

3.03e-0626128995188
Pubmed

Association of MICA and MICB polymorphisms with the susceptibility of leukemia in Korean patients.

MICB MICA

3.03e-06261229895953
Pubmed

Rare and frequent promoter methylation, respectively, of TSHZ2 and 3 genes that are both downregulated in expression in breast and prostate cancers.

TSHZ3 TSHZ2

3.03e-06261221423795
Pubmed

MICB polymorphisms and haplotypes with MICA and HLA alleles in Koreans.

MICB MICA

3.03e-06261221554252
Pubmed

Sodium valproate, a histone deacetylase inhibitor, augments the expression of cell-surface NKG2D ligands, MICA/B, without increasing their soluble forms to enhance susceptibility of human osteosarcoma cells to NK cell-mediated cytotoxicity.

MICB MICA

3.03e-06261221042760
Pubmed

[Expression of MICA/B protein in esophageal cancer and its clinical significance].

MICB MICA

3.03e-06261223291067
Pubmed

Diversification, expression, and gamma delta T cell recognition of evolutionarily distant members of the MIC family of major histocompatibility complex class I-related molecules.

MICB MICA

3.03e-0626129770516
Pubmed

Vertebrate orthologues of the Drosophila region-specific patterning gene teashirt.

TSHZ2 TSHZ1

3.03e-06261210704881
Pubmed

[The polymorphism distributions of MICA and MICB microsatellite in Guangdong Han population].

MICB MICA

3.03e-06261215192843
Pubmed

MICA/B expression is inhibited by unfolded protein response and associated with poor prognosis in human hepatocellular carcinoma.

MICB MICA

3.03e-06261225228093
Pubmed

Association Between Major Histocompatibility Complex Class I Chain-Related Gene Polymorphisms and Susceptibility of Systemic Lupus Erythematosus.

MICB MICA

3.03e-06261229078849
Pubmed

High frequency of MIC null haplotype (HLA-B48-MICA-del-MICB*0107 N) in the Angaite Amerindian community in Paraguay.

MICB MICA

3.03e-06261212242594
Pubmed

MICA, MICB Polymorphisms and Linkage Disequilibrium with HLA-B in a Chinese Mongolian Population.

MICB MICA

3.03e-06261227028549
Pubmed

Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium.

MICB MICA

3.03e-0626128901601
Pubmed

Structure of MHC class I-like MILL2 reveals heparan-sulfate binding and interdomain flexibility.

MICB MICA

3.03e-06261230337538
Pubmed

Association study of MICA and MICB in Alzheimer's disease.

MICB MICA

3.03e-06261219691640
Pubmed

MICB*002 and MICB*014 protect against rheumatoid arthritis, whereas MICA*009 and MICA*A6 are associated with rheumatoid arthritis in a Hainan Han Chinese population.

MICB MICA

3.03e-06261229665245
Pubmed

High resolution MIC genotyping: design and application to the investigation of inflammatory bowel disease susceptibility.

MICB MICA

3.03e-06261212392511
Pubmed

The alteration of placental-derived soluble MHC class I chain-related protein A and B during pregnancy.

MICB MICA

3.03e-06261221426309
Pubmed

Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB.

MICB MICA

3.03e-06261210359807
Pubmed

The association between MICA/MICB polymorphism and respiratory syncytial virus infection in children.

MICB MICA

3.03e-06261228925058
Pubmed

Expression of major histocompatibility complex class I-related chain A/B (MICA/B) in pancreatic carcinoma.

MICB MICA

3.03e-06261224173243
Pubmed

Increased Concentrations of Circulating Soluble MHC Class I-Related Chain A (sMICA) and sMICB and Modulation of Plasma Membrane MICA Expression: Potential Mechanisms and Correlation With Natural Killer Cell Activity in Systemic Lupus Erythematosus.

MICB MICA

3.03e-06261234012432
Pubmed

Wide distribution of the MICA-MICB null haplotype in East Asians.

MICB MICA

3.03e-06261211169252
Pubmed

Major histocompatibility complex class I-related chain A/B (MICA/B) expression in tumor tissue and serum of pancreatic cancer: role of uric acid accumulation in gemcitabine-induced MICA/B expression.

MICB MICA

3.03e-06261221605422
Pubmed

MIC gene polymorphism and haplotype diversity in Zhuang nationality of Southern China.

MICB MICA

3.03e-06261225167773
Pubmed

A new polymorphic and multicopy MHC gene family related to nonmammalian class I.

MICB MICA

3.03e-0626127927538
Pubmed

Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma.

MICB MICA

3.03e-06261214662896
Pubmed

Broad MICA/B expression in the small bowel mucosa: a link between cellular stress and celiac disease.

MICB MICA

3.03e-06261224058482
Pubmed

Diversity and characterisation of polymorphic 3' untranslated region haplotypes of MICA and MICB genes.

MICB MICA

3.03e-06261230471210
Pubmed

Alternatively spliced forms of MICA and MICB lacking exon 3 in a human cell line and evidence of presence of similar RNA in human peripheral blood mononuclear cells.

MICB MICA

3.03e-06261212466900
Pubmed

Epidermal growth factor induction of resistance to topoisomerase II toxins in human squamous carcinoma A431 cells.

EGF TOP2B

3.03e-06261216969495
Pubmed

Immunomodulatory effect of NEDD8-activating enzyme inhibition in Multiple Myeloma: upregulation of NKG2D ligands and sensitization to Natural Killer cell recognition.

MICB MICA

3.03e-06261234482362
Pubmed

Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells.

MICB MICA

3.03e-0626129497295
Pubmed

HLA class I chain-related MICA and MICB genes polymorphism in healthy individuals from the Bulgarian population.

MICB MICA

3.03e-06261235525711
Pubmed

MICB microsatellite polymorphism is associated with ulcerative colitis in Chinese population.

MICB MICA

3.03e-06261216679067
Pubmed

Expression of MICA, MICB and NKG2D in human leukemic myelomonocytic and cervical cancer cells.

MICB MICA

9.07e-06361221477352
Pubmed

Study on the haplotypes of MICA and MICB microsatellite and HLA-B locus in the Guangzhou Han population.

MICB MICA

9.07e-06361215304009
Pubmed

Critical role of MHC class I-related chain A and B expression on IFN-alpha-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection.

MICB MICA

9.07e-06361212538683
Pubmed

Mutual activation of CD4+ T cells and monocytes mediated by NKG2D-MIC interaction requires IFN-gamma production in systemic lupus erythematosus.

MICB MICA

9.07e-06361219200602
Pubmed

Altered microRNA expression after infection with human cytomegalovirus leads to TIMP3 downregulation and increased shedding of metalloprotease substrates, including MICA.

MICB MICA

9.07e-06361224973455
Pubmed

EGF transregulates opioid receptors through EGFR-mediated GRK2 phosphorylation and activation.

GRK2 EGF

9.07e-06361218463167
Pubmed

Activation of tyrosine kinase of EGFR induces Gbetagamma-dependent GRK-EGFR complex formation.

GRK2 EGF

9.07e-06361215620700
Pubmed

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation.

MICB MICA

9.07e-06361212384702
Pubmed

The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia.

MICB MICA

9.07e-06361220428196
Pubmed

Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis.

MICB MICA

9.07e-06361218791713
Pubmed

MHC class I-like MILL molecules are beta2-microglobulin-associated, GPI-anchored glycoproteins that do not require TAP for cell surface expression.

MICB MICA

9.07e-06361216920948
Pubmed

Estrogen upregulates MICA/B expression in human non-small cell lung cancer through the regulation of ADAM17.

MICB MICA

9.07e-06361225363527
Pubmed

Vesicular stomatitis virus infection promotes immune evasion by preventing NKG2D-ligand surface expression.

MICB MICA

9.07e-06361221857986
Pubmed

Associations of major histocompatibility complex class I chain-related molecule polymorphisms with Behcet's disease in Caucasian patients.

MICB MICA

9.07e-06361216101830
Pubmed

Immunostimulation by induced expression of NKG2D and its MIC ligands in HTLV-1-associated neurologic disease.

MICB MICA

9.07e-06361216568261
Pubmed

Adenovirus E3/19K promotes evasion of NK cell recognition by intracellular sequestration of the NKG2D ligands major histocompatibility complex class I chain-related proteins A and B.

MICB MICA

9.07e-06361218287244
Pubmed

MMP9 Promoter Polymorphism (-1562 C/T) Does not Affect the Serum Levels of Soluble MICB and MICA in Breast Cancer.

MICB MICA

9.07e-06361227026046
Pubmed

Genotoxic Stress Induces Senescence-Associated ADAM10-Dependent Release of NKG2D MIC Ligands in Multiple Myeloma Cells.

MICB MICA

9.07e-06361226071561
Pubmed

Midkine upregulates MICA/B expression in human gastric cancer cells and decreases natural killer cell cytotoxicity.

MICB MICA

9.07e-06361222415659
Pubmed

Variation in MICA and MICB genes and enhanced susceptibility to paucibacillary leprosy in South India.

MICB MICA

9.07e-06361216923796
Pubmed

[Expression of NKG2D ligands in multidrug-resistant nasopharyngeal carcinoma cell line CNE2/DDP and their effects on cytotoxicity of natural killer cells].

MICB MICA

9.07e-06361217584663
Pubmed

Promoter region architecture and transcriptional regulation of the genes for the MHC class I-related chain A and B ligands of NKG2D.

MICB MICA

9.07e-06361217202358
Pubmed

Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells.

MICB MICA

9.07e-06361217625602
Pubmed

Reconstructing an ancestral mammalian immune supercomplex from a marsupial major histocompatibility complex.

MICB MICA

9.07e-06361216435885
Pubmed

MHC class I chain-related gene B (MICB) is associated with rheumatoid arthritis susceptibility.

MICB MICA

9.07e-06361217003176
Pubmed

Inactivating mutations in Drosha mediate vascular abnormalities similar to hereditary hemorrhagic telangiectasia.

TJP1 PECAM1

1.81e-05461229339534
Pubmed

Soluble ligands for the NKG2D receptor are released during endometriosis and correlate with disease severity.

MICB MICA

1.81e-05461225775242
Pubmed

Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the "a disintegrin and metalloproteases" 10 and 17.

MICB MICA

1.81e-05461223526433
Pubmed

The role of FREM2 and FRAS1 in the development of congenital diaphragmatic hernia.

FRAS1 PECAM1

1.81e-05461229618029
InteractionTSHZ1 interactions

TSHZ3 TSHZ2 TSHZ1

1.11e-0515603int:TSHZ1
GeneFamilyZinc fingers C2H2-type|ZF class homeoboxes and pseudogenes

TSHZ3 TSHZ2 TSHZ1

6.00e-0615443529
GeneFamilySeptins

SEPTIN11 SEPTIN10

4.44e-0413442732
GeneFamilyZinc fingers C2H2-type|ZF class homeoboxes and pseudogenes

ZNF410 TSHZ3 ZNF562 TSHZ2 ZNF521 TSHZ1 ZNF112

1.61e-0371844728
GeneFamilyC1-set domain containing

MICB MICA

4.68e-0342442591
CoexpressionAtlasdev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000

CFH SLC41A2 HDAC3 COL6A1 FAT4 ACACA TSHZ2 ZNF521 ZC3H12B TSHZ1 ADCY2 ZMAT1 PALLD

1.78e-077835913gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000
CoexpressionAtlasdev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500

CFH SLC41A2 COL6A1 FAT4 TSHZ2 TSHZ1 ADCY2 PALLD

6.20e-06357598gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500
CoexpressionAtlasdev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000

HDAC3 CASP8AP2 ACACA TSHZ2 ZNF521 SEPTIN11 TSHZ1 ADCY2 ZMAT1 PALLD KLHL4

1.48e-058275911gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000
CoexpressionAtlasdev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500

CFH COL6A1 TSHZ2 ADCY2 PALLD

2.25e-05122595gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500
CoexpressionAtlasdev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000

CFH COL6A1 TSHZ2 ZNF521 ZC3H12B ADCY2 PALLD

2.35e-05310597gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000
CoexpressionAtlasdev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000

CFH SLC41A2 COL6A1 FAT4 TSHZ2 ZNF521 TSHZ1 ADCY2 ZMAT1 PALLD

3.33e-057405910gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000
CoexpressionAtlasdev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000

CFH COL6A1 TSHZ2 ZNF521 SEPTIN11 ZC3H12B ADCY2 ZMAT1 PALLD KLHL4

4.56e-057685910gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000
CoexpressionAtlasdev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000

FAT4 FRAS1 TSHZ2 ZNF521 ZC3H12B TSHZ1 ADCY2 ZMAT1 PALLD KLHL4

8.80e-058315910gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000
CoexpressionAtlasdev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000

CFH COL6A1 TSHZ2 ZNF521 ADCY2 PALLD

9.24e-05265596gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000
CoexpressionAtlasDevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_500

CFH FAT4 TSHZ3 DCAF12L1 ZNF521 ADCY2 KLHL4

9.70e-05388597gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500
CoexpressionAtlasDevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#3_top-relative-expression-ranked_500

CFH FAT4 DCAF12L1 ZNF521 KLHL4

1.75e-04188595gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500_k3
CoexpressionAtlasDevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#3_top-relative-expression-ranked_1000

ESCO2 USP34 FAT4 DCAF12L1 ZNF521 ADCY2

2.06e-04307596gudmap_developingKidney_e15.5_Peripheral blastema_1000_k3
CoexpressionAtlasStromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4

CFH TSHZ2 TJP1 PECAM1 ZNF521 SEPTIN10 KLHL4

2.08e-04439597GSM777059_500
CoexpressionAtlasdev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#3_top-relative-expression-ranked_1000

CFH COL6A1 TSHZ2 ZNF521

2.24e-04107594gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k3_1000
CoexpressionAtlasStromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4

CFH TSHZ2 TJP1 PECAM1 ZNF521 SEPTIN10 KLHL4

2.42e-04450597GSM777063_500
CoexpressionAtlasStromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4

FAT4 TSHZ2 TJP1 PECAM1 ZNF521 SEPTIN10 KLHL4

2.72e-04459597GSM777037_500
CoexpressionAtlasdev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000

CFH COL6A1 FRAS1 TSHZ2 ZNF521 SEPTIN11 ZC3H12B ADCY2 PALLD

2.74e-04777599gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000
CoexpressionAtlasDevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000

CFH COL6A1 FAT4 TSHZ3 DCAF12L1 ZNF521 TSHZ1 ADCY2 KLHL4

3.12e-04791599gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000
CoexpressionAtlasdev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000

SLC41A2 HDAC3 FAT4 DCAF12L1 ZNF521 ZC3H12B TSHZ1 ADCY2 PALLD

3.30e-04797599gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000
CoexpressionAtlasdev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000

CFH COL6A1 TSHZ2 ZC3H12B ADCY2 PALLD

3.34e-04336596gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000
ToppCellControl-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations)

CFH COL6A1 FAT4 EPHA6 TSHZ2 ZNF521 SEPTIN11 PALLD

1.87e-10187618bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCellFetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

CFH COL6A1 FAT4 TSHZ3 TSHZ2 ZNF521 SEPTIN11

1.03e-0819861721cf4d81386761d09d0f6829c01c198e5524176d
ToppCellCOVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations)

CFH COL6A1 FAT4 TSHZ2 ZNF521 PALLD

2.63e-07193616e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCellMesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor

COL6A1 FAT4 TSHZ3 FRAS1 TSHZ2 PALLD

2.63e-07193616acad568621ed677031797b8c2e34dafea798d681
ToppCellControl-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations)

CFH COL6A1 TSHZ2 ZNF521 SEPTIN11 PALLD

2.71e-0719461603a269f75a481ea54aea8e6444605db8d6df493d
ToppCellPCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

COL6A1 FAT4 TSHZ3 TSHZ2 SEPTIN11 PALLD

2.88e-07196616dca52c57ba35d9395cdbca8b881f12ece721b10f
ToppCellCOVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations)

CFH COL6A1 TSHZ2 ZNF521 SEPTIN11 PALLD

2.97e-07197616f1c8936986123a3151140c374fcd62d6705c530b
ToppCellLPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

USP34 FAT4 TJP1 PPP1R9A PECAM1 ZNF521

3.24e-07200616dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCellLPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type

FAT4 TJP1 PPP1R9A PECAM1 ZNF521 KLHL4

3.24e-07200616eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1
ToppCellControl|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FRAS1 PPP1R9A PECAM1 HRH1 KLHL4

4.43e-06177615b8ff6940e31b749776e81ae4f5bbd577dba9749c
ToppCellE16.5-samps-Endothelial-Immature_fetal_endothelial-Proliferative_Endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass

ESCO2 TJP1 PECAM1 ZNF521 KLHL4

4.68e-06179615d24513a404c9b1d37dd47aa1cdb5713b64b88f89
ToppCellCOVID-19-Heart-Lymph_EC|Heart / Disease (COVID-19 only), tissue and cell type

TSHZ2 CYP8B1 PECAM1 ZNF521 KLHL4

4.68e-06179615411620201a860716a8773b92f50f7b94ef34a586
ToppCellPCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

COL6A1 TSHZ3 TSHZ2 TSHZ1 GNAO1

5.79e-06187615a9316e2818217ec5feae9cf8816f7249803caee6
ToppCellCOVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type

FAT4 TJP1 PECAM1 HRH1 CTTNBP2NL

5.94e-06188615eecd7482b3c97d7f49993cb17edfab30c61232fc
ToppCellControl-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations)

CFH COL6A1 EPHA6 TSHZ2 ZNF521

5.94e-06188615706a26c372add839d947749f0521a0e1f5c9b0ec
ToppCellMesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor

CFH COL6A1 FAT4 TSHZ2 ZNF521

6.10e-0618961544e37f88137bb249933eb615235b2cf2ae7f3925
ToppCell3'-Adult-LargeIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

COL6A1 LRRIQ1 EPHA6 GNAO1 PALLD

6.10e-06189615f7e2ee5047792ab9ef6472fa88e2d193cdea6fa0
ToppCellPCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

FRAS1 LRRIQ1 EPHA6 PPP1R9A ZMAT1

6.10e-061896157659c7bbd58ee959a159294fb8d17317bbcc5681
ToppCellFetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

TSHZ2 CYP8B1 PECAM1 ZNF521 KLHL4

6.10e-0618961555a1776a4ce049959b3f13a43744c7314bc1f00a
ToppCell3'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

COL6A1 LRRIQ1 EPHA6 GNAO1 PALLD

6.10e-0618961563449d9f1e78ff2bc8786eb88a0d177fe30c7f4d
ToppCellCOVID-19-lung-Artery_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type

FAT4 TJP1 PECAM1 HRH1 CTTNBP2NL

6.26e-0619061507b675befcd1d0a9c90cb17b5d22323468325d51
ToppCellLPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FRAS1 TJP1 PECAM1 ZNF521 HRH1

6.26e-06190615474cbbab8f3b0a6881fa6c92edb78e43999f9ab0
ToppCellPCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

FRAS1 LRRIQ1 EPHA6 PPP1R9A ADCY2

6.42e-0619161560ff989fe99d243a3d52955223680cdd1f1917a4
ToppCellnucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

CFH COL6A1 FAT4 FRAS1 PALLD

6.42e-061916156688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell10x3'2.3-week_14-16-Endothelial-stroma-immature_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

TJP1 ZNF521 SEPTIN10 CTTNBP2NL KLHL4

6.58e-061926155af3b2b38495e925497c48f605d618bbf970965d
ToppCellLPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FRAS1 TJP1 PECAM1 ZNF521 HRH1

6.58e-06192615c618ede75dce3988c87a5b8f98d8e94e1dd66efd
ToppCellLPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FAT4 TJP1 PECAM1 ZNF521 HRH1

6.58e-0619261504f5a2e3dd6beff027b89d66eefdd92036e041af
ToppCellFetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

COL6A1 FAT4 TSHZ2 ZNF521 GNAO1

6.58e-0619261572881b280a415e65f87a80ca1369cbb0b722a0c4
ToppCellLPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FAT4 TJP1 PECAM1 ZNF521 HRH1

6.58e-06192615c07d7b40b2aa4eb27ac85801c014a656e2fd01dc
ToppCellCOVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type

CFH COL6A1 TSHZ3 TSHZ2 SEPTIN11

6.58e-0619261560b1312e84f6d6448365a952469c506c00b5fe93
ToppCellPCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

FRAS1 LRRIQ1 EPHA6 PPP1R9A ZMAT1

6.58e-06192615b99f8236ef4ccdc75c02abea381cae6453205f6f
ToppCellfacs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFH COL6A1 TJP1 PPP1R9A CTTNBP2NL

6.75e-0619361506b65110db974f4ef90d3511ff34428976a52c9c
ToppCellLPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FAT4 TJP1 PPP1R9A PECAM1 ZNF521

6.75e-06193615e09387af84d2a0a526e54d4793e6e06c6739db53
ToppCellfacs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFH COL6A1 TJP1 PPP1R9A CTTNBP2NL

6.75e-061936159c16032bc03df8760ae199e8f19fdafa4c3f1827
ToppCellLPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FAT4 TJP1 PPP1R9A PECAM1 ZNF521

6.75e-061936156e1982d089a9de628e6006d23ff78a223fbd9f47
ToppCellEpithelial-club_cell|World / Lineage, Cell type, age group and donor

ST6GALNAC1 CFH SLC41A2 FRAS1 PPP1R9A

6.75e-061936152bdd09004fa433550958ec42ba4b06271a4aaf7c
ToppCellControl-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FAT4 PPP1R9A PECAM1 ZNF521 HRH1

6.75e-06193615aff0649c73c634bc6ff0dc7759b4693a9236bf05
ToppCellfacs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFH COL6A1 TJP1 PPP1R9A CTTNBP2NL

6.75e-06193615a4f91bca5eaa985982d33a528f7566ffde154d47
ToppCellControl-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FAT4 PPP1R9A PECAM1 ZNF521 HRH1

6.75e-06193615c5f9fe03e64c211d4bcd4959e5b32f14841e336a
ToppCellControl-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FAT4 PPP1R9A PECAM1 ZNF521 KLHL4

6.75e-06193615e1d546165dcc2392f540162206852c4717d7306f
ToppCellfacs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFH COL6A1 TJP1 PPP1R9A CTTNBP2NL

6.75e-06193615b39d7feaac4ff8f7409cd3d15e8f3c6391367275
ToppCellLPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FAT4 TJP1 PECAM1 ZNF521 HRH1

6.92e-0619461543f92b0533e26633dc94cce554045d641ef8fd76
ToppCellLPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FAT4 TJP1 PPP1R9A PECAM1 ZNF521

6.92e-061946150b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCellLPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FAT4 TJP1 PECAM1 ZNF521 HRH1

6.92e-061946151d39d968730a7e85b6161c1c8a6bd38afe9bcad7
ToppCellPCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

FRAS1 LRRIQ1 EPHA6 PPP1R9A ADCY2

6.92e-06194615f95c8dc242c9aebcadfe61b1ed033349cb7e5a88
ToppCellBronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CFH FAT4 TSHZ2 ATP1A4 ADCY2

7.10e-06195615f5e91ce20a7ce528dc4c1a968c7bf096bf45c528
ToppCellPCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

COL6A1 TSHZ3 TSHZ2 TSHZ1 GNAO1

7.28e-0619661522538376a95fe3afe8639a216a5497087aa94110
ToppCell11.5-Distal-Epithelial-Secretory_progenitor|Distal / Age, Tissue, Lineage and Cell class

ST6GALNAC1 CFH SLC41A2 PPP1R9A ADCY2

7.28e-061966152648d64b0e7b59ae78182d55f32699ceea37ff8d
ToppCellParenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CFH COL6A1 FAT4 TSHZ2 ZNF521

7.46e-0619761544673c38384453207871d3fd8e8ba9093cc06bc5
ToppCellParenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CFH FAT4 TSHZ2 ADCY2 PALLD

7.46e-061976156d0d68d460243a0259ada93ebda40fa7b3088eeb
ToppCellIPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class

CFH FAT4 TSHZ2 ZNF521 PALLD

7.46e-06197615f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCellE16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ESCO2 COL6A1 TSHZ2 TSHZ1 PALLD

7.64e-06198615148f5fee19ea8dff7f2de4ca69c3b03e5221985d
ToppCellParenchymal-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

TSHZ2 CYP8B1 PECAM1 ZNF521 KLHL4

7.64e-061986159ab0db78394e730f6866b2db80047149024ad5f6
ToppCellCOVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type

CFH COL6A1 FRAS1 TSHZ2 SEPTIN11

7.64e-06198615df3de77216f5c5d6141ec44d01c56b942f611838
ToppCellBronchial-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

TSHZ2 CYP8B1 PECAM1 ZNF521 KLHL4

7.64e-06198615b3a020522e064bb61949d38e442f24026e339364
ToppCellBronchial-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

TSHZ2 CYP8B1 PECAM1 ZNF521 KLHL4

7.64e-06198615fc4b7c3ad52bc5c8b40fa04a156bfbb58afa2872
ToppCellParenchymal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

TSHZ2 CYP8B1 PECAM1 ZNF521 KLHL4

7.64e-06198615e47d0e2c6353315c85d7007742bb16b0f05795ed
ToppCellFetal_29-31_weeks|World / Lineage, Cell type, age group and donor

CFH COL6A1 FAT4 FRAS1 TSHZ2

7.83e-061996155b9d355795dd03a22f0961dfd143425c367a4654
ToppCellMesenchymal|World / Lineage, Cell type, age group and donor

CFH COL6A1 FAT4 TSHZ2 ZNF521

7.83e-061996154bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCellLPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

COL6A1 FAT4 TSHZ2 TSHZ1 PALLD

7.83e-0619961538cfd367ee8c074c11ba54edeb7a001e375e2687
ToppCellBronchial-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CFH FAT4 ZNF521 SEPTIN11 ADCY2

7.83e-06199615abd6117f8a3d7e798d8471c16d97b34aaf50fc9c
ToppCellLung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-3|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

CFH COL6A1 TSHZ2 SEPTIN11 PALLD

8.02e-06200615e663995fc44c340d878d66b278b7b5c2ff784301
ToppCellcontrol-Epithelial|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

ST6GALNAC1 CFH TSHZ2 TJP1 PALLD

8.02e-06200615f95bbb94e51ac28b1995026c599ec3a34e012916
ToppCellLPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

ST6GALNAC1 DNAH3 LRRIQ1 SPAG8 ADCY2

8.02e-0620061596701a4d57753f5ec0dd5c7550054bbcc946bc5f
ToppCellLung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

CFH COL6A1 TSHZ2 SEPTIN11 PALLD

8.02e-06200615c3d4ce70ab51d74c9fe2f5864e52a4a9d7570e10
ToppCellNS-control-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

ST6GALNAC1 CFH TSHZ2 TJP1 PALLD

8.02e-06200615d014959891893b6d3854a471fba1dc50c6625a0a
ToppCellParenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type

CFH COL6A1 FAT4 FRAS1 PALLD

8.02e-06200615aa1a35dcca3b799241eef4237f6eb94660e019f0
ToppCellLung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-4-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CFH COL6A1 TSHZ2 SEPTIN11 PALLD

8.02e-062006154dbe21cb63569f28c7017cda065ea5ee00d7254e
ToppCellLung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CFH COL6A1 TSHZ2 SEPTIN11 PALLD

8.02e-06200615137f8f9d255c66336d4f8b44b2e3f3de721f2bf0
ToppCellControl_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type

COL6A1 FAT4 TSHZ2 TSHZ1 PALLD

8.02e-06200615a799fc7bb83ad0524362cb5010df949741fb7bf3
ToppCellParenchyma_COVID-19-Stromal-TX-Fibroblasts-4|Parenchyma_COVID-19 / Sample group, Lineage and Cell type

CFH COL6A1 TSHZ2 SEPTIN11 PALLD

8.02e-06200615bde938e5a18844fb8cc1d1be5a086809f7e2b97d
ToppCellTransplant_Alveoli_and_parenchyma-Mesenchymal-Mesothelium|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X

CFH COL6A1 FRAS1 TSHZ2 KLHL4

8.02e-06200615c082bc21ec7c5323439d108ea8aea510e1113c3f
ToppCellLung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

CFH COL6A1 FAT4 FRAS1 PALLD

8.02e-06200615a510deaada669e690329183e18df02870bd204b3
ToppCellLung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-4|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

CFH COL6A1 TSHZ2 SEPTIN11 PALLD

8.02e-062006158256511b099c3eab8e33194f90c9ff354e7cfe8e
ToppCellLung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CFH COL6A1 TSHZ2 SEPTIN11 PALLD

8.02e-062006152cb8a39a12522a9643c6244d5e94cb4559868bb9
ToppCellLung_Parenchyma-Severe-Mesenchymal|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

CFH COL6A1 TSHZ2 SEPTIN11 PALLD

8.02e-062006156ce8e2cf689523993d909a27daec3d6a5824d13c
ToppCellLung_Parenchyma-Severe-Mesenchymal-Mesenchymal|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

CFH COL6A1 TSHZ2 SEPTIN11 PALLD

8.02e-06200615907427e85cebe5a18c8a310e2ffa0e180ea3cb77
ToppCellBronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CFH COL6A1 FAT4 TSHZ2 ZNF521

8.02e-06200615cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCellParenchyma_COVID-19-Stromal-TX-Fibroblasts-3|Parenchyma_COVID-19 / Sample group, Lineage and Cell type

CFH COL6A1 TSHZ2 SEPTIN11 PALLD

8.02e-062006158cc5057b0e5ae9b72ea40d2ffbc52b79bf87ccef
ToppCellLPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

FAT4 TJP1 PPP1R9A PECAM1 ZNF521

8.02e-06200615b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a
ToppCellParenchyma_COVID-19-Stromal-TX-Fibroblasts-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type

CFH COL6A1 TSHZ2 SEPTIN11 PALLD

8.02e-0620061525d3865aa2ced11a5ed40013e83b47d942fdf582
ToppCellFibroblast|World / shred by cell class for parenchyma

CFH COL6A1 TSHZ2 SEPTIN11 PALLD

8.02e-06200615dec9ce1bc2571197003596f32e5f742ede72aa79
ToppCellParenchymal-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

CFH COL6A1 TSHZ2 ARSK SPAG8

8.02e-062006158a4c210a3130f7baedf15ecbc0f4903b97da0352
ToppCellParenchyma_COVID-19-Stromal-TX|Parenchyma_COVID-19 / Sample group, Lineage and Cell type

CFH COL6A1 TSHZ2 SEPTIN11 PALLD

8.02e-062006158472baa74c48b67c5f08223025885c833458290b
ToppCellBronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CFH COL6A1 FAT4 TSHZ3 ZNF521

8.02e-06200615fb53be20392a8309a7393774c774a1b1aec6e676
ToppCellTracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CFH COL6A1 FAT4 TSHZ3 ZNF521

8.02e-0620061558b38f9a484ee94191091a0659ed62ebed2d4a14
ToppCellLung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CFH COL6A1 FAT4 FRAS1 PALLD

8.02e-06200615dd4228cbed8a4395166a6332e08d44d88bebe3b9
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DCAF8 TSHZ2 GNAO1 PALLD

5.34e-051506141270f33f9d7e46e55adf1a96e8beee858b95589d
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DCAF8 TSHZ2 GNAO1 PALLD

5.34e-05150614156118ce1d69522624196410cba18b8354cd0bb4
ToppCellAdult-Epithelial-basal_cell-D122|Adult / Lineage, Cell type, age group and donor

ST6GALNAC1 CFH FRAS1 ADCY2

5.92e-0515461438d346402417960044ae999e61f0092b46f2b591
ToppCellLPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DNAH3 LRRIQ1 SPAG8 ADCY2

6.07e-051556145f1e2195a6b831e1b636f5cc3a282ca423721822
ToppCellLPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DNAH3 LRRIQ1 SPAG8 ADCY2

6.07e-051556140944429459f642a1bcc56edc1ec28aaecde3e2dc
ToppCell3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LRRIQ1 DCAF8 SPAG8 KLHL4

6.70e-051596145543f5aec6352a7c5923e55daf3ed40ff5cc0f0c
ToppCell3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ST6GALNAC1 CFH TSHZ2 ATP1A4

6.70e-051596141baf0eaf9684668146a63192e77eec6c3c7a37f8
ToppCellE16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1|E16.5-samps / Age Group, Lineage, Cell class and subclass

CFH COL6A1 KCNA2 PALLD

7.38e-05163614f1ec2625b52664308968b01d8e0275e1e0751480
ToppCellLPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ST6GALNAC1 DNAH3 LRRIQ1 ADCY2

7.55e-05164614e4d4c59aebe5cacd4ecdb907facd044dc82a831d
ToppCellChildren_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

FAT4 ADCY2 PALLD KLHL4

7.55e-05164614e3983f655cdba308fb192182829f17bef99ce0ba
ToppCellChildren_(3_yrs)-Endothelial-endothelial_cell_of_vein-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

FAT4 CYP8B1 ASMT PECAM1

8.10e-05167614d7fe24cdc4b55a9555ce9e20699f5036b88148e9
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CFH TSHZ2 GNAO1 PALLD

8.29e-05168614d19a115365c5415e51c039718d7669de788fcf33
ToppCelldroplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CFH COL6A1 TSHZ3 ATP1A4

8.29e-05168614d2b91f2adc95dcfa623f8d7ca2df1c6f884da988
DiseaseL lactate dehydrogenase measurement

CFH PTPRJ GNAO1

1.91e-0526593EFO_0004808
DiseaseMHC class I polypeptide-related sequence B measurement

MICB MICA GNAO1

2.97e-0530593EFO_0008234
DiseasePAX-interacting protein 1 measurement

CFH GNAO1

1.09e-048592EFO_0801868
Diseasegdnf family receptor alpha-1 measurement

CFH GNAO1

1.09e-048592EFO_0020400
Diseaselung adenocarcinoma (is_implicated_in)

ESCO2 EGF PTPRJ

1.31e-0449593DOID:3910 (is_implicated_in)
Diseasezinc fingers and homeoboxes protein 3 measurement

CFH GNAO1

1.40e-049592EFO_0803299
DiseaseAdult Hepatocellular Carcinoma

EGF TSC1

1.40e-049592C0279607
DiseaseHLA class II histocompatibility antigen, DQ alpha 2 chain measurement

CFH GNAO1

1.40e-049592EFO_0801686
Diseasecervical carcinoma, Cervical Intraepithelial Neoplasia Grade 2/3

MICA GNAO1

1.75e-0410592EFO_0001061, EFO_1000166
Diseaseovarian cancer (is_marker_for)

HDAC3 EGF PECAM1

3.47e-0468593DOID:2394 (is_marker_for)
Diseasenatural cytotoxicity triggering receptor 3 measurement

CFH MICA

3.52e-0414592EFO_0008243
Diseasecomplement factor H measurement, protein binding measurement

CFH SEPTIN10

3.52e-0414592EFO_0008097, EFO_0010742
DiseaseC-C motif chemokine 19 measurement

CFH GNAO1

3.52e-0414592EFO_0008047
Diseasemucocutaneous lymph node syndrome

PTPRJ MICB GNAO1

4.81e-0476593EFO_0004246
DiseaseGraves disease, thyrotoxic periodic paralysis

MICA GNAO1

5.24e-0417592EFO_0004237, MONDO_0019201
DiseaseAutoimmune Hepatitis

MICA GNAO1

8.05e-0421592EFO_0005676
Diseasehair morphology

FRAS1 EGF

1.54e-0329592EFO_0005038
DiseaseThrombocytopenia

PTPRJ PECAM1

1.54e-0329592C0040034
DiseaseEpileptic encephalopathy

KCNA2 GNAO1

1.65e-0330592C0543888
DiseaseSchizophrenia

ST6GALNAC1 HDAC3 CCDC137 MICB HRH1 SEPTIN11 GNAO1

1.85e-03883597C0036341
DiseaseAutistic Disorder

EGF ASMT PECAM1 TSC1

1.86e-03261594C0004352
Diseaserheumatic heart disease

CFH GNAO1

1.99e-0333592EFO_1001161
Diseasechronic hepatitis C virus infection

MICA GNAO1

1.99e-0333592EFO_0004220

Protein segments in the cluster

PeptideGeneStartEntry
TDHTTETAQGHYMVV

MAMDC4

846

Q6UXC1
SDGAYIHRMQQEAQH

CCDC137

121

Q6PK04
SSDHGELAMEHRQFY

ARSK

311

Q6UWY0
RHAQDTAEGDDVTYM

CTTNBP2NL

121

Q9P2B4
RNNAYGDHVNDSDTM

CXorf66

316

Q5JRM2
EENYHTPEFSQSHMS

FAT4

3081

Q6V0I7
LNHYGMTHVASVSDV

ACACA

1206

Q13085
SEDVYRSHVAGQMLH

CRAT

296

P43155
QTEGQERTPTHYHML

ASMT

306

P46597
EISHGVVAHMSDSYQ

CFH

936

P08603
MATGETNSVYHDDDN

CASP8AP2

826

Q9UKL3
YHLSQHGVFSEADMR

GRK2

281

P25098
YSESHRVHRMQDFDG

RCC1L

216

Q96I51
EEQRFTCYMEHSGNH

MICA

276

Q29983
SHDAESFQMHITQEG

PTPRJ

476

Q12913
ENEDMHGSGVTFHTY

KCNA2

191

P16389
QYIHDGSSTREDSME

FRAS1

1671

Q86XX4
QTQHPHYSREELNSM

EURL

211

Q9NYK6
NMEANSHYGHNDDVR

PECAM1

656

P16284
MEDTGHYSINDENRV

DCAF8

81

Q5TAQ9
EEQRFTCYMEHSGNH

MICB

276

Q29980
HSEDMNATRSEEQFH

KLHL4

146

Q9C0H6
YQASQHDMCRFHSED

HDAC3

51

O15379
NHMHLRTGLSTEYEE

LRRIQ1

91

Q96JM4
TYIHHASGTSMDQDR

OR12D1

251

P0DN82
HSTDRVSMHQDNHGY

PALLD

1276

Q8WX93
INAHHAYESQISSMA

CEP135

936

Q66GS9
SQEHSQEPERQYMHI

ADCY2

956

Q08462
GVVQYSHSQMQEHVS

COL6A1

661

P12109
EQLSSQHHYDYGMRA

DNAH3

1591

Q8TD57
QDIRHMHFDGTDYGT

EGF

491

P01133
QEYVASAMHGDSHDR

TMEM63B

91

Q5T3F8
YTASNPEDEMQHVQH

ESCO2

396

Q56NI9
EAMCHYEDIRSHGNT

MAN2C1

591

Q9NTJ4
QDGIEQHMDFDSRYT

CUL9

211

Q8IWT3
DDMSVYAVGSHSHVS

DCAF12L1

316

Q5VU92
SHSRQYVSGLHMNRE

HRH1

396

P35367
FGYRSVQGDHEMIHS

CYP8B1

111

Q9UNU6
TEMDEHNRPIHTYQV

EPHA6

61

Q9UF33
VTHHDYRMELAQAGT

SPAG8

381

Q99932
NMEDLREQTHTRHYE

SEPTIN11

281

Q9NVA2
SVAEMSAYHHGEQAL

TOP2B

771

Q02880
YDQVLHEDETTNRMH

GNAO1

231

P09471
NSHMGQEIDSHDYVF

ST6GALNAC1

376

Q9NSC7
EQHMEYHSFSEQSFH

SLC41A2

81

Q96JW4
TGVSQDHMRAHYQTG

SLC35B1

186

P78383
YQMSIHLREDSSQTH

ATP1A4

496

Q13733
GTMVEDHRSNSYQDS

ZNF562

26

Q6V9R5
DSVGQLHIMDYNETH

TSC1

1146

Q92574
TVEELYSHMDSHQQP

ZNF521

321

Q96K83
THHLVTMQSGRQSYE

ZNF410

441

Q86VK4
NMEDLREQTHTRHYE

SEPTIN10

306

Q9P0V9
TVHMNETGHYQDDNR

TSHZ2

231

Q9NRE2
VHMNETGHYRDDNHE

TSHZ3

231

Q63HK5
NDSREHMIPEHQYQT

ZC3H12B

781

Q5HYM0
VREDSSGMHHENQTY

TJP1

881

Q07157
DIQHRVHMEENSYNS

ZNF112

431

Q9UJU3
DEFRYQHEQMNATHT

TRIP11

941

Q15643
QSDHRSRHEVSHYSM

USP34

1616

Q70CQ2
LTVHMNETGHYRDDN

TSHZ1

261

Q6ZSZ6
ENSVDTHGYREMVDS

ZMAT1

331

Q5H9K5
DSNNFDGSHVYMHSD

PPP1R9A

386

Q9ULJ8